Tachibana provided third quarter 2025 guidance of total company revenue in the range of $12 million to $14 million and pharma test/services revenue in the range of $11 million to $13 million.
Hosted on MSN
Amkor projects Q3 2025 revenue midpoint of $1.925B while expanding advanced packaging and test capacity
CEO Guillaume Marie Jean Rutten reported second quarter revenue of $1.51 billion, a 14% sequential increase, stating "all end markets showing double-digit sequential growth." Rutten highlighted that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback